Liabilities / Assets
8th percentile
Higher debt load relative to assets than 8% of similar nonprofits.
Siviq Scores
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
0.01x
Liabilities / Revenue
98th percentile
Higher debt load relative to revenue than 98% of similar nonprofits.
Net Margin
1st percentile
Higher net margin than 1% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
37th percentile
Faster asset growth than 37% of similar nonprofits.
Revenue Growth
Score unavailable
A valid growth rate could not be computed from the available filing history.
Balance Sheet
Assets
Up$54,879,660
Up $206,267 (+0.4%) from 2011
Net Assets
Up$54,227,134
Up $198,569 (+0.4%) from 2011
Liabilities
Up$652,528
Up $7,700 (+1.2%) from 2011
Revenue And Expenses
Revenue
Up$25,589
Up $110,878 (+130%) from 2011
Expenses
Down$469,010
Down $100,314 (-18%) from 2011
Net Income
Up-$443,421
Up $211,192 (+32%) from 2011
Historical Trend
Filing Detail Status
This 2012 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
Jump To
Filing Snapshot
- Filing Period
- Oct 1, 2011 to Sep 30, 2012
Mission and Program Overview
Mission
Advancement of scientific and biomedical research through the discovery of cures for human disease.
Document Assets
No mirrored PDF or thumbnail assets are attached yet.
Filings
Displayed year
2012 • Form 990Summary only. Only limited summary data is available for this year.
- Assets
- $54,879,660
- Liabilities
- $652,528
- Net assets
- $54,227,134
- Revenue
- $25,589
- Expenses
- $469,010
- Net income
- -$443,421